RCM
ABMD

Riverhead Capital Management’s Abiomed Inc ABMD Stock Holding History

Riverhead Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$400K Buy
2,250
+500
+29% +$108K 0.01% 817
2019
Q2 		$456K Buy
1,750
+50
+3% +$13.3K 0.02% 758
2019
Q1 		$485K Buy
1,700
+100
+6% +$33.2K 0.02% 721
2018
Q4 		$520K Sell
1,600
-199
-11% -$69.1K 0.02% 645
2018
Q3 		$809K Sell
1,799
-4,489
-71% -$1.77M 0.03% 555
2018
Q2 		$2.57M Buy
6,288
+779
+14% +$282K 0.1% 261
2018
Q1 		$1.6M Buy
5,509
+430
+8% +$109K 0.07% 319
2017
Q4 		$952K Buy
5,079
+1,520
+43% +$284K 0.04% 445
2017
Q3 		$600K Buy
3,559
+439
+14% +$66.4K 0.03% 547
2017
Q2 		$447K Buy
3,120
+1,320
+73% +$177K 0.02% 624
2017
Q1 		$225K Sell
1,800
-480
-21% -$55.6K 0.01% 744
2016
Q4 		$257K Buy
2,280
+690
+43% +$79.9K 0.02% 663
2016
Q3 		$204K Sell
1,590
-59,526
-97% -$7.13M 0.01% 681
2016
Q2 		$2.4M Buy
61,116
+55,416
+972% +$5.51M 0.08% 282
2016
Q1 		$541K Sell
5,700
-1,900
-25% -$160K 0.01% 846
2015
Q4 		$686K Buy
7,600
+5,800
+322% +$492K 0.01% 742
2015
Q3 		$167K Buy
+1,800
New +$159K ﹤0.01% 770

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Riverhead Capital Management's ABMD Position: Q3 2019 in Review

Riverhead Capital Management increased its Abiomed Inc (ABMD) stake by 29% in Q3 2019, buying an estimated $108K and bringing the position to 2,250 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #817.

Riverhead Capital Management first reported a position in ABMD in Q3 2015 and has held it in 17 quarters since. The position peaked at $2.57M in Q2 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Riverhead Capital Management held 2,250 shares of Abiomed Inc worth $400K as of Q3 2019.
  • Riverhead Capital Management bought 500 Abiomed Inc shares in Q3 2019, an estimated $108K.
  • Abiomed Inc made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #817 holding.
  • Riverhead Capital Management first reported a position in Abiomed Inc in Q3 2015 and has held it in 17 quarters since.
  • Riverhead Capital Management's Abiomed Inc position peaked at $2.57M in Q2 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.